36 lakh people with TB are missed by health systems every year..!
World TB Day (WTBD) March 24
Booster for Medical Imaging AI
in India as India-Israel Industrial R&D and Technological Innovation Fund (I4F) Gives Green
Signal
Global Innovation & Technology
Alliance (GITA) on behalf of Department of Science & Technology, Government
of India and Israel Innovation Authority (IIA), on behalf of Government of
Israel, granted HealthNet Global, a part of the Apollo Hospitals Group, India
and Zebra Medical Vision, Israel funding to validate, co-develop and deploy medical imaging Artificial Intelligence (AI) across
India and to increase Tuberculosis (TB) screening capabilities in the rural
areas.
India & Kibbutz Shefayim Israel ,
March 12th 2019 – HealthNet
Global (HNG), a part of the Apollo Hospitals Group, India and Zebra Medical Vision
(Zebra-Med), one of the global leaders in AI Imaging software, Israel announced
today a new collaboration that will focus on validating and deploying AI based
tools at scale across India. The companies shall jointly receive support from India-Israel
Industrial R&D and Technological Innovation Fund (I4F) for their $4.9 Million
project to co-develop and to provide clinical validation, and evidence of the efficacy of radiology
Al based tools in India as per I4F norms.
The final developed project will be able to
assist as a primary screening method for major diseases in large scale
screenings. For example, World Health Organization (WHO) estimates that 3.6 million
people with TB are missed by health systems every year and do not
receive adequate care. This is primarily because patients with TB may present
with mild or no symptoms, particularly early on. Many affected people arrive at
clinics too late with advanced disease or multi-drug resistant TB (MDR-TB),
which is difficult to treat and more likely to cause death. One of the key
strategies to tackling TB is early diagnosis. Unfortunately, sputum testing is only 50% accurate and frequently misses the disease in its early
stages. Both companies will focus on development of AI-based Chest X-ray
interpretation tool for TB which can help address the gap.
Speaking of the initiative, Sangita Reddy, Joint Managing Director, Apollo Hospitals said “When it comes to health, the promise of AI to provide access and improve outcomes in very intriguing. There is a critical need to provide good healthcare access in remote and rural communities, and we believe this initiative will allow us the opportunity to make significant advances in this area. Apollo’s clinical and scientific depth and Zebra-Med’s expertise in AI complement each other perfectly. This project is part of our continuing endeavor to design new tools to improve healthcare access and deliver best outcomes to patients at lower cost.”
In addition to leveraging clinical depth
and breadth of the Apollo Hospitals network, HNG will work in close
collaboration with Apollo Radiology International, a distinguished part of
Apollo Hospitals, to bring in leadership, experience and technology in
Radiology reporting to the project. The
partnership will capitalize on the advancements already achieved by Zebra-ed in
developing dozens of AI tools. The arsenal of algorithms will include deep
learning algorithms for the detection of acute conditions such as brain bleeds
in head CTs and Pneumothorax in chest X-ray, detection of breast cancer in
mammograms, Osteoporosis in CT scans and 40 other conditions.
“We are excited to partner with the
leading healthcare services provider in India and to help bring AI to India at
such a scale, “ noted EyalGura,
Co-founder and CEO of Zebra-Med. “When we met the Indian team for the
first time few years ago we found common ground and similar dream of scaling
healthcare from millions to billions of patients. We are honored that the two
governments have placed their trust in us and we are committed to utilize this
opportunity to impact millions of lives.”
The grant will aid the partners to focus on
development of India specific algorithms tool which would be of immense benefit
to patients across India and other emerging nations. The project will also
modify existing algorithms to make them suitable for the Indian population. The
final product will assist provide high quality radiology access to remote
locations by alerting the presence of critical findings immediately. This will
help provide timely, cost-effective, quality care to patients in remote and
rural locations.
“This is an exciting
time for AI in medicine,” said Vikram
Thaploo, CEO of HNG. “As these systems increase in accuracy, so will the
viability of using AI to extend the reach of Chest X-Ray interpretation,
improve reporting efficiency and save lives. We believe in the impact that
technology can have in helping provide timely, cost-effective, quality care to
patients in remote locations and our partnership with Zebra-Med is a step in
this journey.”
“We believe that this
project will be a very important milestone in the introduction of AI in Indian
healthcare. We are excited to provide clinical leadership and expertise to this
initiative”, said Dr. Sreenivasa Raju
Kalidindi, CEO and Medical Director of Apollo Radiology International.
About
HealthNet Global Ltd. (HNG)
HealthNet
Global, a part of the Apollo Hospitals Group, provides integrated solutions and
services for connected health and continuum of care through Remote healthcare
services.
HNG is a pioneer company in India for integrated telemedicine
solutions with connected devices, connected software for tele consultations.
HNG provides services to help governments to enhance the quality of Public
Health, Operations of Healthcare Systems (PPP) and Emergency and Healthcare
Management services.
About Apollo Hospitals Enterprise Ltd.
(AHEL)
The Apollo Hospitals Group is Asia’s
largest and most trusted healthcare group, and its presence includes 10,164
beds across 70+ Hospitals, 3,272 Pharmacies, over 200 Primary Care and
Diagnostic Clinics, 500 plus Telemedicine Centres and over 180 plus Apollo Munich
Insurance branches panning the length and breadth of the country.
As an
integrated healthcare service provider with health insurance services, projects
consultancy services, medical education centers and a Research Foundation with
a focus on global clinical trials, epidemiological studies, stem cell &
genetic research, the Apollo Hospitals Group has been at the forefront of new
medical breakthroughs with the most recent investment being that of
commissioning the first Proton Therapy Centre across Asia, Africa and Australia
in Chennai, India.
Every four days, the Apollo Hospitals Group touches a
million lives, in its mission to bring healthcare of International standards
within the reach of every individual.
About Zebra
Medical Vision (Zebra-Med)
Zebra Medical Vision uses deep
learning to create and provide next generation products and services to the
healthcare industry.
Its Imaging Analytics Platform allows healthcare
institutions to identify patients at risk of disease, and offer improved,
preventative treatment pathways to improve patient care.
Headquartered in
Kibbutz Shefayim Israel, Zebra was founded in 2014 by Co-Founders EyalToledano,
EyalGura, and Elad Benjamin and funded by Khosla Ventures, Marc Benioff,
Intermountain Investment Fund, OurCrowdQure, Aurum, aMoon, Nvidia, J&J,
and Dolby Ventures. For more information, visit www.zebra-med.com.
No comments:
Post a Comment